Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sequential is a biotechnology company specializing in skin microbiome testing and data analysis for the personal care and pharmaceutical industries. The company provides an end-to-end platform that utilizes proprietary non-invasive sampling and next-generation sequencing to evaluate the impact of products on the skin's microbial ecosystem. By offering both B2B clinical trial services and consumer-facing diagnostic tools, Sequential has developed one of the world's most comprehensive databases of skin microbiome samples. Their technology enables brands to validate product efficacy, support microbiome-friendly claims, and discover new biomarkers for skin health. Sequential's mission is to advance precision health through a deeper understanding of the human microbiome across the skin, scalp, and oral environments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sequential.